Proteomics International Laboratories Ltd: Change of Director's Interest Notice
Proteomics International Laboratories Ltd: Issue of Equity Incentives to Employees
Proteomics International Laboratories Ltd: Proteomics appoints medical devices sales agency for Europe
Proteomics International Laboratories Ltd: Change of auditor entity
Proteomics International Laboratories Ltd: Promarker technology used for diagnosing plant dieback
Proteomics International Laboratories Ltd: March 2024 Quarterly Activities Report and Appendix 4C
Proteomics International Laboratories Ltd: Proteomics signs with Oxford Univ to validate test for Endo
Proteomics International Laboratories Ltd: PromarkerD US commercialisation & Promarker pipeline update
Proteomics International Laboratories Ltd: Proteomics International retains its ISO13485 certification
Proteomics International Laboratories Ltd: European patent granted for OxiDx technology
Proteomics International Laboratories Ltd: Study validates biomarkers for endometriosis blood test
Proteomics International Laboratories Ltd: Study validates biomarkers for oesophageal cancer blood test
Proteomics International Laboratories Ltd: Change of Director's Interest Notice
Proteomics International Laboratories Ltd: December 2023 Quarterly Activities Report and Appendix 4C
Proteomics International Laboratories Ltd: PromarkerD licence with Omics Global extended to Chile
Proteomics International Laboratories Ltd: US Medicare confirms reimbursement price for PromarkerD
Proteomics International Laboratories Ltd: Proteomics presents at Bell Potter Healthcare Conference
Proteomics International Laboratories Ltd: Proteomics receives $1.85 million in R&D tax incentive
Proteomics International Laboratories Ltd: Update on presentation to the ASN Conference
Proteomics International Laboratories Ltd: September 2023 Quarterly Activities Report and Appendix 4C
No Data